Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
IJMS | Free Full-Text | Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease
Frontiers | Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
JPM | Free Full-Text | Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer's Disease
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives | SpringerLink
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
New Alzheimer's Biomarkers may Support Early Diagnosis
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor | ACS Applied Materials & Interfaces
Clinical significance of fluid biomarkers in Alzheimer's Disease | SpringerLink
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease | Science Advances
Frontiers | Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection
